Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Astera Labs (ALAB) EBITDA (2023 - 2025)

Astera Labs' EBITDA history spans 3 years, with the latest figure at $45.2 million for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 118.24% year-over-year to $45.2 million, compared with a TTM value of $223.0 million through Dec 2025, up 367.88%, and an annual FY2025 reading of $223.0 million, up 367.88% over the prior year.
  • EBITDA for Q4 2025 was $45.2 million at Astera Labs, down from $92.3 million in the prior quarter.
  • The five-year high for EBITDA was $92.3 million in Q3 2025, with the low at -$93.3 million in Q1 2024.
  • Average EBITDA over 3 years is $9.5 million, with a median of $6.0 million recorded in 2023.
  • Year-over-year, EBITDA crashed 441.07% in 2024 and then surged 3384.85% in 2025.
  • Tracing ALAB's EBITDA over 3 years: stood at $14.9 million in 2023, then surged by 39.0% to $20.7 million in 2024, then surged by 118.24% to $45.2 million in 2025.
  • Per Business Quant, the three most recent readings for ALAB's EBITDA are $45.2 million (Q4 2025), $92.3 million (Q3 2025), and $52.1 million (Q2 2025).